The JAK2V617F and CALR exon 9 mutations are shared immunogenic neoantigens in hematological malignancy by Morten Orebo Holmström, Hans Carl Hasselbalch, Mads Hald Andersen

Get full text

Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies by Uffe Klausen, Staffan Holmberg, Staffan Holmberg, Morten Orebo Holmström, Morten Orebo Holmström, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund, Jacob Handlos Grauslund, Inge Marie Svane, Inge Marie Svane, Mads Hald Andersen, Mads Hald Andersen

Get full text

Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation by Mia Aaboe Jørgensen, Morten Orebo Holmström, Evelina Martinenaite, Caroline Hasselbalch Riley, Hans Carl Hasselbalch, Mads Hald Andersen

Get full text

Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and... by Morten Orebo Holmström, Caroline Hasselbalch Riley, Vibe Skov, Inge Marie Svane, Hans Carl Hasselbalch, Mads Hald Andersen

Get full text

Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enric... by Morten Orebo Holmström, Morten Orebo Holmström, Morten Andersen, Sofie Traynor, Shamaila Munir Ahmad, Thomas Landkildehus Lisle, Jacob Handlos Grauslund, Vibe Skov, Lasse Kjær, Johnny T. Ottesen, Morten Frier Gjerstorff, Morten Frier Gjerstorff, Hans Carl Hasselbalch, Mads Hald Andersen, Mads Hald Andersen

Get full text

1138 TGFβ-specific T cells recognize megakaryocyte progenitors in patients with myeloproliferative neoplasms by Vibe Skov, Lasse Kjær, Hans Hasselbalch, Mads Andersen, Morten Orebo Holmström, Maria Perez Penco, Thomas Lisle, Josephine Hallundbæk Ruders, Jacob Handlos Grauslund

An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial by Jacob Handlos Grauslund, Morten Orebo Holmström, Morten Orebo Holmström, Evelina Martinenaite, Evelina Martinenaite, Thomas Landkildehus Lisle, Hannah Jorinde Glöckner, Daniel El Fassi, Uffe Klausen, Uffe Klausen, Rasmus E. J. Mortensen, Nicolai Jørgensen, Lasse Kjær, Vibe Skov, Inge Marie Svane, Hans Carl Hasselbalch, Mads Hald Andersen, Mads Hald Andersen

Get full text

Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy by Mads Hald Andersen, Özcan Met, Inge Marie Svane, Morten Orebo Holmström, Thomas Landkildehus Lisle, Rasmus Erik Johansson Mortensen, Jane P Hasselby, Gro L Willemoe, Julia Johansen, Dorte L Nielsen, Inna M Chen

Get full text

Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV by Uffe Klausen, Uffe Klausen, Uffe Klausen, Jacob Handlos Grauslund, Jacob Handlos Grauslund, Nicolai Grønne Dahlager Jørgensen, Nicolai Grønne Dahlager Jørgensen, Nicolai Grønne Dahlager Jørgensen, Shamaila Munir Ahmad, Merete Jonassen, Stine Emilie Weis-Banke, Evelina Martinenaite, Lone Bredo Pedersen, Thomas Landkildehus Lisle, Anne Ortved Gang, Lisbeth Enggaard, Morten Hansen, Morten Orebo Holmström, Morten Orebo Holmström, Özcan Met, Inge Marie Svane, Carsten Utoft Niemann, Lars Møller Pedersen, Mads Hald Andersen, Mads Hald Andersen

Get full text

First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer by Sofie Kirial Mørk, Per Kongsted, Marie Christine Wulff Westergaard, Benedetta Albieri, Joachim Stoltenborg Granhøj, Marco Donia, Evelina Martinenaite, Evelina Martinenaite, Morten Orebo Holmström, Morten Orebo Holmström, Kasper Madsen, Anders H. Kverneland, Julie Westerlin Kjeldsen, Rikke Boedker Holmstroem, Cathrine Lund Lorentzen, Nis Nørgaard, Lars Vibe Andreasen, Grith Krøyer Wood, Dennis Christensen, Michael Schantz Klausen, Sine Reker Hadrup, Per thor Straten, Per thor Straten, Mads Hald Andersen, Mads Hald Andersen, Inge Marie Svane

Get full text

Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8+T cells by Olivia Lie-Andersen, Olivia Lie-Andersen, Olivia Lie-Andersen, Mie Linder Hübbe, Mie Linder Hübbe, Krishanthi Subramaniam, Daniel Steen-Jensen, Ann Christina Bergmann, Daniel Justesen, Morten Orebo Holmström, Lance Turtle, Sune Justesen, Telma Lança, Morten Hansen

Get full text

The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines by Stine Emilie Weis-Banke, Mie Linder Hübbe, Morten Orebo Holmström, Mia Aaboe Jørgensen, Simone Kloch Bendtsen, Evelina Martinenaite, Marco Carretta, Inge Marie Svane, Niels Ødum, Ayako Wakatsuki Pedersen, Özcan Met, Daniel Hargbøl Madsen, Mads Hald Andersen

Get full text

Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells by Marco Donia, Mads Hald Andersen, Özcan Met, Lars Grøntved, Daniel Hargbøl Madsen, Inge Marie Svane, Mia Aaboe Jørgensen, Stine Emilie Weis-Banke, Morten Orebo Holmström, Thomas Landkildehus Lisle, Maria Perez-Penco, Aimilia Schina, Mie Linder Hübbe, Majken Siersbæk, Niels Ødum

Get full text

TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer by Marco Donia, Mads Hald Andersen, Lars Grøntved, Daniel Hargbøl Madsen, Inés Lecoq, Evelina Martinenaite, Mia Aaboe Jørgensen, Stine Emilie Weis-Banke, Morten Orebo Holmström, Maria Perez-Penco, Aimilia Schina, Mie Linder Hübbe, Majken Siersbæk, Niels Ødum, Lucia Lara de la Torre, Simone Kloch Bendtsen

Get full text

Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment by Simone Kloch Bendtsen, Maria Perez-Penco, Mie Linder Hübbe, Evelina Martinenaite, Morten Orebo Holmström, Stine Emilie Weis-Banke, Nicolai Grønne Dahlager Jørgensen, Mia Aaboe Jørgensen, Shamaila Munir Ahmad, Kasper Mølgaard Jensen, Christina Friese, Mia Thorup Lundsager, Astrid Zedlitz Johansen, Marco Carretta, Niels Ødum, Özcan Met, Inge Marie Svane, Daniel Hargbøl Madsen, Mads Hald Andersen

Get full text

Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression by Ana Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, Anne Rahbech, Marlies J. W. Peeters, Aneta Radziwon-Balicka, Carlos Zamora, Tobias Wirenfeldt Klausen, Vibe Skov, Lasse Kjær, Christina Ellervik, Christina Ellervik, Christina Ellervik, Daniel El Fassi, Daniel El Fassi, Silvia Vidal, Hans Carl Hasselbalch, Mads Hald Andersen, Mads Hald Andersen, Per thor Straten, Per thor Straten

Get full text

Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression by Ana Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, Anne Rahbech, Marlies J. W. Peeters, Aneta Radziwon-Balicka, Carlos Zamora, Tobias Wirenfeldt Klausen, Vibe Skov, Lasse Kjær, Christina Ellervik, Christina Ellervik, Christina Ellervik, Daniel El Fassi, Daniel El Fassi, Silvia Vidal, Hans Carl Hasselbalch, Mads Hald Andersen, Mads Hald Andersen, Per thor Straten, Per thor Straten

Get full text